WallStreetZenWallStreetZen

NASDAQ: XFOR
X4 Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
X4 Pharmaceuticals earnings were -$95.1M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest XFOR earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$29.8M, up 15.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, XFOR reported annual earnings of -$37.5M, with -63% growth.

XFOR earnings history

Current Revenue
$34.0M
Current Earnings
-$95.1M
Current Profit Margin
-279.9%

XFOR Return on Equity

Current Company
-343.7%
Current Industry
-21.2%
Current Market
35.1%
XFOR's Return on Equity (-343.7%)... subscribe to Premium to read more.
High Return on Equity Performance

XFOR undefined

Current Company
-69.8%
Current Industry
-8.8%
XFOR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when XFOR announces earnings.

XFOR undefined

Current Company
-61.27%
Current Industry
-3.4%
XFOR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

XFOR vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
XFOR-$81.78M-$95.10MN/A-$10.12
LCTX-$66.99M-$67.66MN/A-$0.29
RCKT-$227.85M-$240.91MN/A-$2.25
KYTX-$156.09M-$160.99MN/A-$3.73
PEPG-$92.73M-$93.56MN/A-$2.82
View Top Biotech Stocks

X4 Pharmaceuticals Earnings Reports & History FAQ

What were X4 Pharmaceuticals's earnings last quarter?

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q3 2025 earnings per share (EPS) of -$0.69, up 87.41% year over year. Total XFOR earnings for the quarter were -$29.82 million. In the same quarter last year, X4 Pharmaceuticals's earnings per share (EPS) was -$5.48.

If you're new to stock investing, here's how to buy X4 Pharmaceuticals stock.

Is X4 Pharmaceuticals profitable or losing money?

As of the last X4 Pharmaceuticals earnings report, X4 Pharmaceuticals is currently losing money. X4 Pharmaceuticals's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$95.10 million, a 467.43% increase year over year.

What was XFOR's earnings growth in the past year?

As of X4 Pharmaceuticals's earnings date in Q4 2025, X4 Pharmaceuticals's earnings has grown year over year. XFOR earnings in the past year totalled -$95.10 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.